2026-06-04 01:45:07
Latest Post
Alembic Pharmaceuticals Appoints Mr. Ramesh Juneja as Executive Vice President - Human Health (Sales and Marketing), India Business
Second Half Recovery Limits Nifty Losses to 78 Points; IT Index Tanks 5.5%
Akums Receives European CEP Approval for Cefpodoxime Proxetil
Tunwal E-Motors Reports Strong FY26 Results; Revenue Surges 55% to ₹276.84 Crore
Sharika Enterprises Enters High-Growth SCADA-ADMS Market with Uttarakhand Grid Modernization Project
Research
Buy SBI for target of Rs.957 : Kotak Securities PCG
Posted On : 2006-01-31 01:57:19( TIMEZONE : IST )
Kotak Securities Private Client Research has kept Buy rating on SBI at the current market price of Rs.913 for a target Rs.957.